The Mark Foundation for Cancer Research – MFCR shared ESMO’s post, adding:
“Congratulations to 2022 Mark Foundation Emerging Leader Award winner Dan Landau on this well-deserved honor!”
ESMO – Eur. Oncology shared:
“The ESMO26 Award for Translational Research recognises Dan Landau pioneering contributions to advancing our understanding of cancer evolution through innovative genomic and computational research.
‘Resistance taught us that cancer evolves faster than we can respond. The next step is to turn that around: to read a tumour’s evolutionary history well enoug to forecast its future.’
– Dan A. Landau.”
You can also read:
